Search Results - "Maria Teresa Garcia Morales"

TransFAIR study: a European multicentre experimental comparison of EHR2EDC technology to the usual manual method for eCRF data collection by Ammour, Nadir, Griffon, Nicolas, Djadi-Prat, Juliette, Chatellier, Gilles, Lewi, Martine, Todorovic, Marija, Gómez de la Cámara, Augustín, García Morales, Maria Teresa, Testoni, Sara, Nanni, Oriana, Schindler, Christoph, Sundgren, Mats, Garvey, Almenia, Victor, Tomothy, Cariou, Manon, Daniel, Christel

“…PurposeRegulatory authorities including the Food and Drug Administration and the European Medicines Agency are encouraging to conduct clinical trials using…”
Get full text

Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study by Gauffin, Oskar, Brand, Judith S., Vidlin, Sara Hedfors, Sartori, Daniele, Asikainen, Suvi, Català, Martí, Chalabi, Etir, Dedman, Daniel, Danilovic, Ana, Duarte-Salles, Talita, García Morales, Maria Teresa, Hiltunen, Saara, Jödicke, Annika M., Lazarevic, Milan, Mayer, Miguel A., Miladinovic, Jelena, Mitchell, Joseph, Pistillo, Andrea, Ramírez-Anguita, Juan Manuel, Reyes, Carlen, Rudolph, Annette, Sandberg, Lovisa, Savage, Ruth, Schuemie, Martijn, Spasic, Dimitrije, Trinh, Nhung T. H., Veljkovic, Nevena, Vujovic, Ankica, de Wilde, Marcel, Zekarias, Alem, Rijnbeek, Peter, Ryan, Patrick, Prieto-Alhambra, Daniel, Norén, G. Niklas

“…Introduction Individual case reports are the main asset in pharmacovigilance signal management. Signal validation is the first stage after signal detection and…”
Get full text

No changes in hemostasis after COVID-19–heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS study by Butta, Nora V., Arias-Salgado, Elena G., Monzón Manzano, Elena, Acuña, Paula, Álvarez Román, María Teresa, Buño-Soto, Antonio, Ramos Ramos, Juan Carlos, Belda-Iniesta, Cristóbal, Frías, Jesús, Carcas, Antonio J., de Soto, Lucía Martínez, de Miguel Buckley, Rosa, Lora, David, García-Morales, María Teresa, Borobia, Alberto M., Arribas, José Ramón, Jiménez Yuste, Víctor

“…Several cases of unusual thrombotic events and thrombocytopenia were described after vaccination with recombinant adenoviral vectors encoding the spike protein…”
Get full text

Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical Trial by García-García, Irene, Seco-Meseguer, Enrique, Ruiz-Seco, Pilar, Navarro-Jimenez, Gema, Martínez-Porqueras, Raúl, Espinosa-Díaz, María, Ortega-Albás, Juan José, Sagastagoitia, Iñigo, García-Morales, María Teresa, Jiménez-González, María, Martínez de Soto, Lucía, Bajo-Martínez, Ana Isabel, Del Palacio-Tamarit, María, López-García, Raquel, Díaz-García, Lucía, Queiruga-Parada, Javier, Giesen, Christine, Pérez-Villena, Ana, de Castro-Martínez, Marta, González-García, Juan J, Rodriguez-Rubio, Miguel, de la Oliva, Pedro, Arribas, José R, Carcas, Antonio J, Borobia, Alberto M

“…We evaluated in this randomised, double-blind clinical trial the efficacy of melatonin as a prophylactic treatment for prevention of SARS-CoV-2 infection among…”
Get full text

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial by Carcas, Antonio J, Pérez-Olmeda, Mayte, Castaño, Luis, Bertran, María Jesús, García-Pérez, Javier, García Morales, María Teresa, Arana-Arri, Eunate, Díez-Fuertes, Francisco, Fuentes, Inmaculada, Ascaso, Ana, Lora, David, Imaz-Ayo, Natale, Gómez de la Cámara, Agustín, Ochando, Jordi, Alcamí, José, Belda-Iniesta, Cristóbal, Frías, Jesús, Martínez de Soto, Lucía, Díaz García, Lucía, Ramírez García, Elena, Stewart Balbás, Stefan Mark, García García, Irene, Urroz Elizalde, Mikel, Sanz García, Marta, Mauleón Martínez, Vega, de Madariaga Castell, Raquel, Vitón Vara, Laura, Buño, Antonio, López Granados, Eduardo, Cámara, Carmen, Ayllon García, Pilar, Jiménez González, María, Sánchez, Amparo, de la Calle, Fernando, Arsuaga, Marta, Meijide, Susana, García de Vicuña, Aitor, Santorcuato, Ana, Expósito, Iraide, de Benito, Sara, Andia, Joseba, Irurzun, Esther, Camino, Jesús, Temprano, Mikel, Gallego, Mikel, García-Vázquez, Dolores, de la Hoz, Ana Belén, Pérez-Nanclares, Gustavo, Idoyaga, Eneko, Lamela, Adriana, Castillo de la Osa, María, Andrés Galván, María Elena, Calonge, Esther, Bermejo, Mercedes, de la Torre-Tarazona, Erick Humberto, Fedele, Giovanni, Cervera, Isabel, Bodega-Mayor, Irene, Montes-Casado, María, Portolés, Pilar, Granés, Laura, Lazaar, Sulayman, Mellado, María Eugènia, Tortajada, Marta, Quesada, Sebastiana, Olivé, Victoria, Gómez, Begoña, González, Elisenda, Casals, Cristina, Burunat, Laura, Fernández, Patricia, Vila, Jordi, Armadans, Lluis, Borras-Bermejo, Blanca, Calonge, Julia, Camacho, Lina, Feliu, Anna, Gili, Gisela, Martínez-Gómez, Xavier, Parés, Oleguer, Riera-Arnau, Judit, Rodrigo-Pendás, José Angel, Sans, Carla, Santos, José, Torres, Gloria, Uriona, Sonia, Pérez Esquirol, Eulàlia, Laredo Velasco, Leonor, Uribe López, Diana, González Rojano, Esperanza, Sánchez-Craviotto, Manuel, Gil Marín, José Antonio, Navalpotro, Ana Belén, Jiménez-Santamaría, M Dolores, Cardós, M Carmen, Hermoso, Elena, Domingo Fernández, Alexandra, López Picado, Amanda, Quiñones, Jorge Mario, García-Franco, Ana

“…To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity…”
Get full text

Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study by Voss, Erica A., Shoaibi, Azza, Yin Hui Lai, Lana, Blacketer, Clair, Alshammari, Thamir, Makadia, Rupa, Haynes, Kevin, Sena, Anthony G., Rao, Gowtham, van Sandijk, Sebastiaan, Fraboulet, Clement, Boyer, Laurent, Le Carrour, Tanguy, Horban, Scott, Morales, Daniel R., Martínez Roldán, Jordi, Ramírez-Anguita, Juan Manuel, Mayer, Miguel A., de Wilde, Marcel, John, Luis H., Duarte-Salles, Talita, Roel, Elena, Pistillo, Andrea, Kolde, Raivo, Maljković, Filip, Denaxas, Spiros, Papez, Vaclav, Kahn, Michael G., Natarajan, Karthik, Reich, Christian, Secora, Alex, Minty, Evan P., Shah, Nigam H., Posada, Jose D., Garcia Morales, Maria Teresa, Bosca, Diego, Cadenas Juanino, Honorio, Diaz Holgado, Antonio, Pedrera Jiménez, Miguel, Serrano Balazote, Pablo, García Barrio, Noelia, Şen, Selçuk, Üresin, Ali Yağız, Erdogan, Baris, Belmans, Luc, Byttebier, Geert, Malbrain, Manu L.N.G., Dedman, Daniel J., Cuccu, Zara, Vashisht, Rohit, Butte, Atul J., Patel, Ayan, Dahm, Lisa, Han, Cora, Bu, Fan, Arshad, Faaizah, Ostropolets, Anna, Nyberg, Fredrik, Hripcsak, George, Suchard, Marc A., Prieto-Alhambra, Dani, Rijnbeek, Peter R., Schuemie, Martijn J., Ryan, Patrick B.

“…Adverse events of special interest (AESIs) were pre-specified to be monitored for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines,…”
Get full text

Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort studyResearch in context by Erica A. Voss, Azza Shoaibi, Lana Yin Hui Lai, Clair Blacketer, Thamir Alshammari, Rupa Makadia, Kevin Haynes, Anthony G. Sena, Gowtham Rao, Sebastiaan van Sandijk, Clement Fraboulet, Laurent Boyer, Tanguy Le Carrour, Scott Horban, Daniel R. Morales, Jordi Martínez Roldán, Juan Manuel Ramírez-Anguita, Miguel A. Mayer, Marcel de Wilde, Luis H. John, Talita Duarte-Salles, Elena Roel, Andrea Pistillo, Raivo Kolde, Filip Maljković, Spiros Denaxas, Vaclav Papez, Michael G. Kahn, Karthik Natarajan, Christian Reich, Alex Secora, Evan P. Minty, Nigam H. Shah, Jose D. Posada, Maria Teresa Garcia Morales, Diego Bosca, Honorio Cadenas Juanino, Antonio Diaz Holgado, Miguel Pedrera Jiménez, Pablo Serrano Balazote, Noelia García Barrio, Selçuk Şen, Ali Yağız Üresin, Baris Erdogan, Luc Belmans, Geert Byttebier, Manu L.N.G. Malbrain, Daniel J. Dedman, Zara Cuccu, Rohit Vashisht, Atul J. Butte, Ayan Patel, Lisa Dahm, Cora Han, Fan Bu, Faaizah Arshad, Anna Ostropolets, Fredrik Nyberg, George Hripcsak, Marc A. Suchard, Dani Prieto-Alhambra, Peter R. Rijnbeek, Martijn J. Schuemie, Patrick B. Ryan

“…Background: Adverse events of special interest (AESIs) were pre-specified to be monitored for the COVID-19 vaccines. Some AESIs are not only associated with…”
Get full text

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study by García-Pérez, Javier, González-Pérez, María, Castillo de la Osa, María, Borobia, Alberto M., Castaño, Luis, Bertrán, María Jesús, Campins, Magdalena, Portolés, Antonio, Lora, David, Bermejo, Mercedes, Conde, Patricia, Hernández-Gutierrez, Lourdes, Carcas, Antonio, Arana-Arri, Eunate, Tortajada, Marta, Fuentes, Inmaculada, Ascaso, Ana, García-Morales, María Teresa, Erick de la Torre-Tarazona, Humberto, Arribas, José-Ramón, Imaz-Ayo, Natale, Mellado-Pau, Eugènia, Agustí, Antonia, Pérez-Ingidua, Carla, Gómez de la Cámara, Agustín, Ochando, Jordi, Belda-Iniesta, Cristobal, Frías, Jesús, Alcamí, José, Pérez-Olmeda, Mayte

“…The CombiVacS study was designed to assess immunogenicity and reactogenicity of the heterologous ChAdOx1-S/BNT162b2 combination, and 14-day results showed a…”
Get full text

Predictive Power of the "Trigger Tool" for the detection of adverse events in general surgery: a multicenter observational validation study by Pérez Zapata, Ana Isabel, Rodríguez Cuéllar, Elías, de la Fuente Bartolomé, Marta, Martín-Arriscado Arroba, Cristina, García Morales, María Teresa, Loinaz Segurola, Carmelo, Giner Nogueras, Manuel, Tejido Sánchez, Ángel, Ruiz López, Pedro, Ferrero Herrero, Eduardo

“…In spite of the global implementation of standardized surgical safety checklists and evidence-based practices, general surgery remains associated with a high…”
Get full text

KRAS/NRAS/BRAF genotyping in patients with mestastatic colorectal cancer by Rodriguez Salas, Nuria, Miranda, Jesus, Ostios, Lorena, Muñoz, Mario, Borobia, Alberto, Gordo, Gema, Tenorio, Jair, Tong, Hoi, García Morales, Maria Teresa, Martinez Avila, Jose Carlos

“…Abstract only 718 Background: mCRC is the 2º cause of death in the world. Development of targeted therapies has increased the survival. The efficacy of these…”
Get full text

No changes in haemostasis after COVID-19-heterologous vaccination schedule: a sub analysis of the phase 2 CombiVacS study by Butta, Nora V., Arias-Salgado, Elena G., Manzano, Elena Monzón, Acuña, Paula, Álvarez Román, María Teresa, Buño-Soto, Antonio, Ramos Ramos, Juan Carlos, Belda-Iniesta, Cristóbal, Frías, Jesús, Carcas, Antonio J., Martínez de Soto, Lucía, de Miguel Buckley, Rosa, Lora, David, García-Morales, María Teresa, Borobia, Alberto M., Arribas, José Ramón, Yuste, Víctor Jiménez

Get full text